Blog
RSS FeedPosted by Michael Wonder on 01 Feb 2024
Biden-Harris Administration to make first offer for drug price negotiation program, launches new resource hub to help people access lower cost drugs
1 February 2024 - Department of Human and Health Services also releases new research showing that the United States pays ...
Posted by Michael Wonder on 30 Jan 2024
Pharma price cut proposals from US Government could be steep, analysts say
29 January 2024 - Pharmaceutical companies are due to receive by Thursday the US Government's opening proposal for what are ...
Posted by Michael Wonder on 29 Jan 2024
Will Medicare push drug prices down in 2024?
29 January 2024 - Medicare participants will get insight this year into how much the prices of certain drugs will ...
Posted by Michael Wonder on 29 Jan 2024
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
26 January 2024 - Bristol Myers Squibb CEO Chris Boerner and another unnamed pharmaceutical CEO accepted initial invitations to testify. ...
Posted by Michael Wonder on 25 Jan 2024
Hospital prices for physician administered drugs for patients with private insurance
25 January 2024 - In this study, we used 2020–2021 national Blue Cross Blue Shield claims data regarding patients in the ...
Posted by Michael Wonder on 23 Jan 2024
Lower drug costs are just a federal license away. But they require Biden Administration leadership.
23 January 2024 - It’s a longstanding Government failure to never use federal “march-in” licensing rights to lower drug prices. It’s ...
Posted by Michael Wonder on 22 Jan 2024
Generic drugs in the US are too cheap to be sustainable, experts say
19 January 2024 - Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of ...
Posted by Michael Wonder on 22 Jan 2024
In ‘march-in’ rights, some see a tool to lower drug prices. Others see a threat to intellectual property.
22 January 2024 - In the fall of 2020, Robert Sachs was prescribed a medication to treat prostate cancer that had ...
Posted by Michael Wonder on 19 Jan 2024
Medicare patients on pricey drugs are saving big this year
15 January 2024 - For the first time, Part D plan patients will hit a ceiling on how much they pay ...
Posted by Michael Wonder on 18 Jan 2024
Drug makers raise prices of Ozempic, Mounjaro and hundreds of other drugs
18 January 2024 - Companies hiked prices of 775 brand name drugs at start of new year. ...
Posted by Michael Wonder on 17 Jan 2024
Launch and post-launch prices of injectable cancer drugs in the US: clinical benefit, innovation, epidemiology and competition
17 January 2024 - We aimed to identify and quantify factors associated with launch prices and post-launch price changes of ...
Posted by Michael Wonder on 17 Jan 2024
Prescription Drug Affordability Act aims to set limits on high medication prices
17 January 2024 - Lawmakers in Springfield are focusing on high prescription drug prices. ...
Posted by Michael Wonder on 03 Jan 2024
Drug makers set to raise US prices on at least 500 drugs in January
29 December 2023 - Drug makers including Pfizer, Sanofi and Takeda plan to raise prices in the United States on ...
Posted by Michael Wonder on 01 Jan 2024
How lowering the price of a common asthma drug made it harder to get
29 December 2023 - To avoid Medicaid penalties, Glaxo and other drug makers lowered prices. ...
Posted by Michael Wonder on 29 Dec 2023
Biden Administration’s Medicare drug price negotiations will face major tests in 2024
28 December 2023 - US patients and drug makers will get a first glimpse of how much Medicare can negotiate down ...